Host innate immune responses induced by baculovirus in mammals

Current Gene Therapy

Volumn 10, Issue 3, 2010, Pages 226-231

  Abe, Takayuki ^a   Matsuura, Yoshiharu ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Baculovirus; IFN; Innate immunity; TLR; Vector

Indexed keywords

BACULOVIRUS VECTOR; GLYCOPROTEIN B; GLYCOPROTEIN E2; INFLUENZA VIRUS HEMAGGLUTININ; INTERFERON; MANNOSE RECEPTOR; MYELOID DIFFERENTIATION FACTOR 88; OVALBUMIN; PATTERN RECOGNITION RECEPTOR; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 9; VIRUS DNA;

ARTICLE; AUTOGRAPHA CALIFORNICA; BACULOVIRUS; CYTOKINE PRODUCTION; GENE DELIVERY SYSTEM; GENETIC TRANSCRIPTION; GENETIC TRANSDUCTION; HEPATITIS C VIRUS; HOST RESISTANCE; HUMORAL IMMUNITY; IMMUNOGENICITY; INNATE IMMUNITY; INSECT CELL; MAMMAL; NONHUMAN; POLYHEDROSIS VIRUS; PSEUDORABIES HERPETOVIRUS; VIRUS INDUCTION; VIRUS INFECTION; VIRUS RECOMBINANT;

ANIMALS; BACULOVIRIDAE; CYTOKINES; DNA REPLICATION; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; MAMMALS; MICE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

AUTOGRAPHA CALIFORNICA NUCLEOPOLYHEDROVIRUS; HEXAPODA; MAMMALIA; MUS;

EID: 77953653494     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652310791321279     Document Type: Article

References (74)

1. Matsuura Y, Possee RD, Overton HA, et al. Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins. J Gen Virol 1987; 68(Pt 5): 1233-50.
2. Luckow VA, Summers MD. Signals important for high-level expression of foreign genes in Autographa californica nuclear poly-hedrosis virus expression vectors. Virology 1988; 167(1): 56-71.
3. Hofmann C, Sandig V, Jennings G, et al. Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc Natl Acad Sci USA 1995; 92(22): 10099-103.
4. Boyce FM, Bucher NL. Baculovirus-mediated gene transfer into mammalian cells. Proc Natl Acad Sci USA 1996; 93(6): 2348-52.
5. Shoji I, Aizaki H, Tani H, et al. Efficient gene transfer into various mammalian cells, including non-hepatic cells, by baculovirus vectors. J Gen Virol 1997; 78(Pt 10): 2657-64.
6. Tani H, Nishijima M, Ushijima H, et al. Characterization of cell-surface determinants important for baculovirus infection. Virology 2001; 279(1): 343-53.
7. Tani H, Limn CK, Yap CC, et al. In vitro and in vivo gene delivery by recombinant baculoviruses. J Virol 2003; 77(18): 9799-808.
8. Gronowski AM, Hilbert DM, Sheehan KC, et al. Baculovirus stimulates antiviral effects in mammalian cells. J Virol 1999; 73(12): 9944-51.
9. Beck NB, Sidhu JS, Omiecinski CJ. Baculovirus vectors repress phenobarbital-mediated gene induction and stimulate cytokine expression in primary cultures of rat hepatocytes. Gene Ther 2000; 7(15): 1274-83.
10. Abe T, Takahashi H, Hamazaki H, et al. Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice. J Immunol 2003; 171(3): 1133-9.
11. Abe T, Hemmi H, Miyamoto H, et al. Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by Baculovirus. J Virol 2005; 79(5): 2847-58.
12. Abe T, Kaname Y, Wen X, et al. Baculovirus induces type I inter-feron production through toll-like receptor-dependent and -independent pathways in a cell-type-specific manner. J Virol 2009; 83(15): 7629-40.
13. Hervas-Stubbs S, Rueda P, Lopez L, et al. Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN. J Immunol 2007; 178(4): 2361-9.
14. Kitajima M, Abe T, Miyano-Kurosaki N, et al. Induction of natural killer cell-dependent antitumor immunity by the Autographa cali-fornica multiple nuclear polyhedrosis virus. Mol Ther 2008; 16(2): 261-8.
15. Wilson S, Baird M, Ward VK. Delivery of vaccine peptides by rapid conjugation to baculovirus particles. Vaccine 2008; 26(20): 2451-6.
16. Boulaire J, Zhao Y, Wang S. Gene expression profiling to define host response to baculoviral transduction in the brain. J Neurochem 2009; 109(5): 1203-14.
17. Chen GY, Shiah HC, Su HJ, et al. Baculovirus transduction of mesenchymal stem cells triggers the toll-like receptor 3 pathway. J Virol 2009; 83(20): 10548-56.
18. Han Y, Niu M, An L, et al. Upregulation of proinflammatory cyto-kines and NO production in BV-activated avian macrophage-like cell line (HD11) requires MAPK and NF-kappaB pathways. Int Immunopharmacol 2009; 9(78): 817-23.
19. Boublik Y, Di Bonito P, Jones IM. Eukaryotic virus display: engineering the major surface glycoprotein of the Autographa califor-nica nuclear polyhedrosis virus (AcNPV) for the presentation of foreign proteins on the virus surface. Biotechnology (NY) 1995; 13(10): 1079-84.
20. Oker-Blom C, Airenne KJ, Grabherr R. Baculovirus display strategies: emerging tools for eukaryotic libraries and gene delivery. Brief Funct Genomic Proteomic 2003; 2(3): 244-53.
21. Kost TA, Condreay JP, Jarvis DL. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol 2005; 23(5): 567-75.
22. Lindley KM, Su JL, Hodges PK, et al. Production of monoclonal antibodies using recombinant baculovirus displaying gp64-fusion proteins. J Immunol Methods 2000; 234(1-2): 123-35.
23. Tanaka T, Takeno T, Watanabe Y, et al. The generation of monoclonal antibodies against human peroxisome proliferator-activated receptors (PPARs). J Atheroscler Thromb 2002; 9(5): 233-42.
24. Aoki H, Sakoda Y, Jukuroki K, et al. Induction of antibodies in mice by a recombinant baculovirus expressing pseudorabies virus glycoprotein B in mammalian cells. Vet Microbiol 1999; 68(3-4): 197-207.
25. Facciabene A, Aurisicchio L, La Monica N. Baculovirus vectors elicit antigen-specific immune responses in mice. J Virol 2004; 78(16): 8663-72.
26. Yoshida S, Kondoh D, Arai E, et al. Baculovirus virions displaying Plasmodium berghei circumsporozoite protein protect mice against malaria sporozoite infection. Virology 2003; 316(1): 161-70.
27. Yoshida S, Araki H, Yokomine T. Baculovirus-based nasal drop vaccine confers complete protection against malaria by natural boosting of vaccine-induced antibodies in mice. Infect Immun 2010; 78(2): 595-602.
28. Strauss R, Huser A, Ni S, et al. Baculovirus-based vaccination vectors allow for efficient induction of immune responses against plasmodium falciparum circumsporozoite protein. Mol Ther 2007; 15(1): 193-202.
29. Kaba SA, Nene V, Musoke AJ, et al. Fusion to green fluorescent protein improves expression levels of Theileria parva sporozoite surface antigen p67 in insect cells. Parasitology 2002; 125(Pt 6): 497-505.
30. Fang R, Feng H, Nie H, et al. Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB/c mice model. Vaccine 2010; 28(7): 1803-07.
31. Rahman MM, Shaila MS, Gopinathan KP. Baculovirus display of fusion protein of Peste des petits ruminants virus and hemaggluti-nation protein of Rinderpest virus and immunogenicity of the displayed proteins in mouse model. Virology 2003; 317(1): 36-49.
32. Tami C, Peralta A, Barbieri R, et al. Immunological properties of FMDV-gP64 fusion proteins expressed on SF9 cell and Baculovirus surfaces. Vaccine 2004; 23(6): 840-5.
33. Grabowska AK, Lipinska AD, Rohde J, et al. New baculovirus recombinants expressing Pseudorabies virus (PRV) glycoproteins protect mice against lethal challenge infection. Vaccine 2009; 27(27): 3584-91.
34. Yang DG, Chung YC, Lai YK, et al. Avian influenza virus hemag-glutinin display on baculovirus envelope: cytoplasmic domain affects virus properties and vaccine potential. Mol Ther 2007; 15(5): 989-96.
35. Mangor JT, Monsma SA, Johnson MC, et al. A GP64-null bacu-lovirus pseudotyped with vesicular stomatitis virus G protein. J Virol 2001; 75(6): 2544-56.
36. Lung O, Westenberg M, Vlak JM, et al. Pseudotyping Autographa californica multicapsid nucleopolyhedrovirus (AcMNPV): F proteins from group II NPVs are functionally analogous to AcMNPV GP64. J Virol 2002; 76(11): 5729-36.
37. Kitagawa Y, Tani H, Limn CK, et al. Ligand-directed gene targeting to mammalian cells by pseudotype baculoviruses. J Virol 2005; 79(6): 3639-52.
38. Blissard GW, Wenz JR. Baculovirus gp64 envelope glycoprotein is sufficient to mediate pH-dependent membrane fusion. J Virol 1992; 66(11): 6829-35.
39. Jarvis DL, Garcia A, Jr. Biosynthesis and processing of the Auto-grapha californica nuclear polyhedrosis virus gp64 protein. Virology 1994; 205(1): 300-13.
40. Monsma SA, Blissard GW. Identification of a membrane fusion domain and an oligomerization domain in the baculovirus GP64 envelope fusion protein. J Virol 1995; 69(4): 2583-95.
41. Monsma SA, Oomens AG, Blissard GW. The GP64 envelope fusion protein is an essential Baculovirus protein required for cell-to-cell transmission of infection. J Virol 1996; 70(7): 4607-16.
42. Wang P, Hammer DA, Granados RR. Binding and fusion of Auto-grapha californica nucleopolyhedrovirus to cultured insect cells. J Gen Virol 1997; 78(Pt 12): 3081-9.
43. Markovic I, Pulyaeva H, Sokoloff A, et al. Membrane fusion mediated by baculovirus gp64 involves assembly of stable gp64 trimers into multiprotein aggregates. J Cell Biol 1998; 143(5): 1155-66.
44. Oomens AG, Blissard GW. Requirement for GP64 to drive efficient budding of Autographa californica multicapsid nucleopolyhe drovirus. Virology 1999; 254(2): 297-314.
45. Jarvis DL, Finn EE. Biochemical analysis of the N-glycosylation pathway in baculovirus-infected lepidopteran insect cells. Virology 1995; 212(2): 500-11.
46. Apostolopoulos V, McKenzie IF. Role of the mannose receptor in the immune response. Curr Mol Med 2001; 1(4): 469-74.
47. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124(4): 783-801.
48. Hemmi H, Takeuchi O, Kawai T, et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408(6813): 740-5.
49. Chuang CK, Wong TH, Hwang SM, et al. Baculovirus transduction of mesenchymal stem cells: in vitro responses and in vivo immune responses after cell transplantation. Mol Ther 2009; 17(5): 889-96.
50. Yoneyama M, Kikuchi M, Natsukawa T, et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004; 5(7): 730-7.
51. Yoneyama M, Kikuchi M, Matsumoto K, et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 2005; 175(5): 2851-8.
52. Kawai T, Takahashi K, Sato S, et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 2005; 6(10): 981-8.
53. Honda K, Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 2006; 6(9): 644-58.
54. Kadowaki N, Antonenko S, Lau JY, et al. Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J Exp Med 2000; 192(2): 219-26.
55. Gilliet M, Cao W, Liu YJ. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 2008; 8(8): 594-606.
56. Diebold SS, Kaisho T, Hemmi H, et al. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004; 303(5663): 1529-31.
57. Malmgaard L, Melchjorsen J, Bowie AG, et al. Viral activation of macrophages through TLR-dependent and -independent pathways. J Immunol 2004; 173(11): 6890-8.
58. Nociari M, Ocheretina O, Schoggins JW, et al. Sensing infection by adenovirus: Toll-like receptor-independent viral DNA recognition signals activation of the interferon regulatory factor 3 master regulator. J Virol 2007; 81(8): 4145-57.
59. Zhu J, Huang X, Yang Y. Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways. J Virol 2007; 81(7): 3170-80.
60. Hochrein H, Schlatter B, O'Keeffe M, et al. Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways. Proc Natl Acad Sci USA 2004; 101(31): 11416-21.
61. Waibler Z, Anzaghe M, Ludwig H, et al. Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses. J Virol 2007; 81(22): 12102-10.
62. Seiler MP, Cerullo V, Lee B. Immune response to helper dependent adenoviral mediated liver gene therapy: challenges and prospects. Curr Gene Ther 2007; 7(5): 297-305.
63. Follenzi A, Santambrogio L, Annoni A. Immune responses to lentiviral vectors. Curr Gene Ther 2007; 7(5): 306-15.
64. Mingozzi F, High KA. Immune responses to AAV in clinical trials. Curr Gene Ther 2007; 7(5): 316-24.
65. Kato H, Sato S, Yoneyama M, et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 2005; 23(1): 19-28.
66. Ishii KJ, Coban C, Kato H, et al. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat Immunol 2006; 7(1): 40-8.
67. Charrel-Dennis M, Latz E, Halmen KA, et al. TLR-independent type I interferon induction in response to an extracellular bacterial pathogen via intracellular recognition of its DNA. Cell Host Microbe 2008; 4(6): 543-54.
68. Chessler AD, Ferreira LR, Chang TH, et al. A novel IFN regulatory factor 3-dependent pathway activated by trypanosomes triggers IFN-beta in macrophages and fibroblasts. J Immunol 2008; 181(11): 7917-24.
69. Stetson DB, Medzhitov R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 2006; 24(1): 93-103.
70. Takaoka A, Wang Z, Choi MK, et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007; 448(7152): 501-5.
71. Ishikawa H, Barber GN. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 2008; 455(7213): 674-8.
72. Zhong B, Yang Y, Li S, et al. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 2008; 29(4): 538-50.
73. Ishii KJ, Kawagoe T, Koyama S, et al. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature 2008; 451(7179): 725-9.
74. Ishikawa H, Ma Z, Barber GN. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 2009; 461(7265): 788-92.